APOTHEEK STEGEN
ActiveSummary
APOTHEEK STEGEN has been active since 1974 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €547,605 and a net result of €5,889. Equity has been stable since 2018 (±0.3% per year). Its solvency ranks better than 88% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 01-02-1974 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730and 1 other
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.010.425.661 2280 Grobbendonk, since 01-02-1974
- Financial year end
- 31 December
- Peppol
- Reachable since 04-12-2025
Board and ownership
- Lira Pharma BVDirector · since 01-01-2018
- Lira Pharma100%2025 annual accounts of Lira Pharma
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €164,085
- ▼ 39.0%
- Turnover
- ≈ €770,000
- estimated
- Profit
- €5,889
- ▼ 93.2%
- Equity
- €547,605
- ▲ 1.1%
- Total assets
- €701,156
- ▼ 5.4%
- Employees on 31-12-2025
- 3
- =
- 2025 accounts filed 5 days after the deadline
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 4.49, cash €178,268Equity €547,605 (78.1% of total assets)Founded in 1974Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 80% on liquidity, 37% on profitability and 43% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 12 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Comparable companies
These companies have the same main activity as APOTHEEK STEGEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €554,000 and €792,000, founded between 1969 and 1987.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK STEGEN Grobbendonk | €701,156 | €164,085 |
| Apotheek P. Hostens Antwerpen | €738,383 | €205,352 |
| MEER APOTHEEK Hoogstraten | €705,802 | €168,352 |
| PHARMACIE CRAHAY Chaudfontaine | €618,494 | €161,018 |
| Pharmacie TASSIN Beyne-Heusay | €791,772 | €195,181 |
| Pharmacie du progrès Charleroi | €553,649 | €175,234 |
| POELMAN Tessenderlo-Ham | €709,941 | €179,864 |
Key facts about APOTHEEK STEGEN
- What is the company number of APOTHEEK STEGEN?
- The company number of APOTHEEK STEGEN is 0413.990.951. The VAT number is the same number with BE in front: BE 0413.990.951.
- Where is APOTHEEK STEGEN based?
- The registered office is at Astridplein 37, 2280 Grobbendonk.Company details
- What does APOTHEEK STEGEN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK STEGEN?
- The legal form of APOTHEEK STEGEN is Private limited company (BV).
- When was APOTHEEK STEGEN founded?
- APOTHEEK STEGEN was founded on 01-02-1974.
- Is APOTHEEK STEGEN still active?
- Yes, APOTHEEK STEGEN is an active enterprise in the KBO register.
- How many employees does APOTHEEK STEGEN have?
- APOTHEEK STEGEN had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK STEGEN fall under?
- In its 2025 annual accounts, APOTHEEK STEGEN states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK STEGEN?
- The turnover in financial year 2025 is ≈ €770,000. This figure is estimated from the gross margin of €164,085 and 51 comparable companies (NACE 477). It probably lies between €520,000 and €1.5m.
- Is APOTHEEK STEGEN profitable?
- In financial year 2025, APOTHEEK STEGEN made a profit of €5,889.
- Where can I find the annual accounts of APOTHEEK STEGEN?
- APOTHEEK STEGEN filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK STEGEN due?
- APOTHEEK STEGEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.